Skip to main content

MIDFUT


MIDFUT has completed active follow up as of 31/08/2024 and is now in the analysis phase until 28/02/2024


MIDFUT Trial information for participants

This page provides information about treatments used in the MIDFUT trial only. Any queries regarding diabetic foot ulcer care should be made with a member of your healthcare team. This is not an exhaustive list and other information is also available.

Treatment as usual (TAU)

Here are some links with information about TAU:

National Institute for Health and Care Excellence guidance: Diabetic foot problems: prevention and management

National Institute for Health and Care Excellence: Managing a diabetic foot problem

National Institute for Health and Care Excellence: general information

Hydrosurgical Debridement (HD)

Here are some links with information about HD:

Information about the VERSAJET◊ II device

Information about Smith and Nephew

Decellularised dermal allograft (DCD)

Here are some links with information about DCD:

Information about DCD

Information about NHS Blood and Transplant (NHSBT)

Negative pressure wound therapy (NPWT)

Here are some links with information about NPWT:

Information about the RENASYS◊ GO device

Information about Smith and Nephew

Further information on the MIDFUT study is available using the links below

UK clinical trials gateway

ISRCTN website

MIDFUT Study results

If you would like to receive an email notification when the study results are published please use the link below and enter your email address into the ‘alerts and updates’ tab:

MIDFUT Journals Library